168 Results for "

PDGFr-β

" in MedChemExpress (MCE) Product Catalog:
Products (168)

168 Results for "PDGFr-β" in MCE Product Catalog:

Cat. No.: HY-13904S
Synonyms: HHGV678-d3
Flumatinib-d3 is deuterium labeled Flumatinib. Flumatinib (HHGV678) is an orally available, selective inhibitor of Bcr-Abl. Flumatinib inhibits c-Abl, PDGFRβ and c-Kit with IC50s of 1.2 nM, 307.6 nM and 665.5 nM, respectively .
loading...
    loading...
Cat. No.: HY-10065S1
CAS No.: 1126623-89-9
Purity:  98.03%
Synonyms: AG-013736-d3
Axitinib-d3 (AG-013736-d3) is deuterium labeled Axitinib. Axitinib is a multi-targeted tyrosine kinase inhibitor with IC50s of 0.1, 0.2, 0.1-0.3, 1.6 nM for VEGFR1, VEGFR2, VEGFR3 and PDGFRβ, respectively .
loading...
    loading...
Cat. No.: HY-19624
CAS No.: 300842-64-2
Synonyms: ACC-789; ZK202650
Target:  

VEGFR PDGFR

Research Areas:  

Cancer

NVP-ACC789 is an inhibitor of human VEGFR-1, VEGFR-2 (mouse VEGFR-2), VEGFR-3 and PDGFR-β with IC50s of 0.38, 0.02 (0.23), 0.18, 1.4 μM, respectively.
loading...
    loading...
Cat. No.: HY-123450
CAS No.: 1257628-57-1
Purity:  99.60%
Target:  

Bcr-Abl Apoptosis PDGFR

Research Areas:  

Cancer

S116836, a potent, orally active BCR-ABL tyrosine kinase inhibitor, blocks both wild-type as well as T315I Bcr-Abl. S116836 arrests the cells in the G0/G1 phase of cell cycle, induces apoptosis, increases ROS production, and decreases GSH production in BaF3/WT and BaF3/T315I cells. S116836 also inhibits SRC, LYN, HCK, LCK and BLK, and receptor tyrosine kinases such as FLT3, TIE2, KIT, PDGFR-β. Antitumor activies . S116836 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
loading...
    loading...
Cat. No.: HY-I0678
CAS No.: 835621-11-9
Target:  

Drug Metabolite PDGFR

Research Areas:  

Cancer

Regorafénib N-oxyde M2 is an active metabolite of Regorafenib. Regorafenib is a multi-target inhibitor for VEGFR1/2/3, PDGFRβ, Kit, RET and Raf-1 with IC50s of 13/4.2/46, 22, 7, 1.5 and 2.5 nM, respectively.
loading...
    loading...
Cat. No.: HY-112345
CAS No.: 179343-17-0
Purity:  98.07%
Target:  

FGFR PDGFR EGFR Src

Research Areas:  

Cancer

PD-089828 is an ATP competitive inhibitor of FGFR-1, PDGFR-β and EGFR (IC50s=0.15, 1.76, and 5.47 µM, respectively) and a noncompetitive inhibitor of c-Src tyrosine kinase (IC50=0.18 µM). PD-089828 also inhibits MAPK with an IC50 of 7.1 µM. PD-089828 inhibits PDGF-, EGF- and bFGF-mediated tyrosine kinase receptor autophosphorylation in vitro. PD-089828 has a long-lasting cellular activity .
loading...
    loading...
Cat. No.: HY-108627
CAS No.: 1123491-15-5
Purity:  99.10%
Target:  

PDGFR

Research Areas:  

Others

DMPQ dihydrochloride is a potent and selective inhibitor of human platelet-derived growth factor receptor β (PDGFRβ) with an IC50 of 80 nM .
loading...
    loading...
Cat. No.: HY-10501A
CAS No.: 849643-15-8
Purity:  99.04%
Target:  

PDGFR VEGFR c-Kit

Research Areas:  

Cancer

SU14813 maleate is a multi-targeted receptor tyrosine kinases inhibitor with IC50s of 50, 2, 4, 15 nM for VEGFR2, VEGFR1, PDGFRβ and KIT.
loading...
    loading...
Cat. No.: HY-13493
CAS No.: 1351522-04-7
Purity:  98.56%
Target:  

PDGFR c-Kit FLT3

Research Areas:  

Cancer

AC710 is a potent PDGFR inhibitor with Kds of 0.6, 1.57, 1, 1.3, 1.0 nM for FLT3, CSF1R, KIT, PDGFRα and PDGFRβ, respectively.
loading...
    loading...
Cat. No.: HY-160053
Target:  

PDGFR

Research Areas:  

Cancer

Gint4.T aptamer sodium is a nuclease-resistant RNA aptamer-based antagonist targeting platelet-derived growth factor receptor beta (PDGFRβ) (Kd: 9.6 nM). Gint4.T aptamer sodium inhibits PDGFRβ heterodimerization and EGFR transactivation. It can significantly inhibit cell migration and proliferation, induce differentiation and prevent tumor growth in vivo. Gint4.T aptamer sodium specifically inhibits PDGFRβ-mediated tropism of mesenchymal stem cells (MSCs) toward the tumor microenvironment .
loading...
    loading...
Cat. No.: HY-172275A
Target:  

Liposome

Research Areas:  

Inflammation/Immunology

DSPE-PEG2000-pPB is a PEG compound which composed of DSPE and a cyclic oligopeptide (pPB). pPB has a strong binding affinity with PDGFRβ, which is overexpressed on activated hepatic stellate cells (HSC). DSPE-PEG2000-pPB can be used for drug delivery .
loading...
    loading...
Cat. No.: HY-10873S
CAS No.: 1217247-62-5
N-Desethyl Sunitinib-d5 is the deuterium labeled N-Desethyl Sunitinib. N-Desethyl Sunitinib (SU-12662) is a metabolite of sunitinib. Sunitinib is a potent, ATP-competitive VEGFR, PDGFRβ and KIT inhibitor with Ki values of 2, 9, 17, 8 and 4 nM for VEGFR -1, -2, -3, PDGFRβ and KIT, respectively .
loading...
    loading...
Cat. No.: HY-10208S
CAS No.: 1219592-01-4
Purity:  ≥98.0%
Synonyms: GW786034-d6
Pazopanib-d6 is the deuterium labeled Pazopanib. Pazopanib (GW786034) is a novel multi-target inhibitor of VEGFR1, VEGFR2, VEGFR3, PDGFRβ, c-Kit, FGFR1, and c-Fms with IC50s of 10, 30, 47, 84, 74, 140 and 146 nM, respectively.
loading...
    loading...
Cat. No.: HY-10407G
CAS No.: 215543-92-3
SU 5402 (GMP) is SU 5402 (HY-10407) produced by using GMP guidelines. GMP small molecules work appropriately as an auxiliary reagent for cell therapy manufacture. SU 5402 is a potent multi-targeted receptor tyrosine kinase inhibitor with IC50 of 20 nM, 30 nM, and 510 nM for VEGFR2, FGFR1, and PDGFRβ, respectively .
loading...
    loading...
Cat. No.: HY-120640
CAS No.: 639858-32-5
Purity:  99.57%
Target:  

VEGFR PDGFR

Research Areas:  

Cancer

BMS-605541 is a selective and orally active inhibitor of VEGFR-2 kinase with an IC50 value of 23 nM and Ki value of 49 nM. BMS-605541 inhibits the activity of Flk-1, VEGFR-1 and PDGFR-β with IC50 values of 40 nM, 400 nM and 200 nM, respectively. BMS-605541 can be used for cancer research .
loading...
    loading...
Cat. No.: HY-15198
CAS No.: 877874-85-6
Purity:  99.79%
Target:  

Raf PDGFR FLT3 c-Kit

Research Areas:  

Cancer

KG5 is an orally active dual PDGFRβ and B-Raf allosteric inhibitor. KG5 also inhibits Flt3, KIT and c-Raf. KG5 has anticancer, antiangiogenic activities .
loading...
    loading...
Cat. No.: HY-10255AS1
CAS No.: 1126721-79-6
Sunitinib-d4 is the deuterium labeled Sunitinib. Sunitinib (SU 11248) is a multi-targeted receptor tyrosine kinase inhibitor with IC50s of 80 nM and 2 nM for VEGFR2 and PDGFRβ, respectively . Sunitinib, an ATP-competitive inhibitor, effectively inhibits autophosphorylation of Ire1α by inhibiting autophosphorylation and consequent RNase activation .
loading...
    loading...
Cat. No.: HY-110272
CAS No.: 212142-18-2
Synonyms: PTK787 succinate; ZK-222584 succinate; CGP-79787 succinate
Target:  

VEGFR

Research Areas:  

Cancer

Vatalanib (PTK787) succinate is a potent and orally active VEGFR inhibitor with IC50s of 37 nM, 77 nM, 270 nM, 660 nM, 730 nM, 1400 nM, and 580 nM for KDR, Flt-1, Flk, Flt-4, c-Kit, c-Fms, and PDGFR-β, respectively .
loading...
    loading...
Cat. No.: HY-155684
CAS No.: 3058085-76-7
Research Areas:  

Cancer

SA-PA is an intracellular self-assembling CRBN-recruiting PROTAC composed of an alkynylated Sorafenib precursor (SA) and an azidated Pomalidomide precursor (PA). SA-PA promotes the ubiquitination and proteasomal degradation of VEGFR-2, EphB4, and PDGFR-β, and exhibits inhibitory activity against U87 and A549 cell proliferation. SA-PA is used in cancer-related research, such as glioblastoma and non-small cell lung cancer .
loading...
    loading...
Cat. No.: HY-13493A
CAS No.: 1351522-05-8
Target:  

PDGFR

Research Areas:  

Cancer

AC710 Mesylate is a potent PDGFR inhibitor with Kds of 0.6, 1.57, 1, 1.3, 1.0 nM for FLT3, CSF1R, KIT, PDGFRα and PDGFRβ, respectively.
loading...
    loading...